This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEET
CONDENSED CONSOLIDATED BALANCE SHEET (Parenthetical)
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Notes to Financial Statements
Nature of Operations
Risks and Liquidity
Business Combination
Summary of Significant Accounting Policies
Recent Accounting Guidance
Pfizer License Agreement
Equity Commitment and Share Purchase Option
Fair Value Measurements
Financial Statement Components
Leases
Stockholders' Equity
Equity-Based Compensation
Net Loss Per Share
Income Taxes
Legal Proceedings
Commitments and Contingencies
Employee Benefit Plans
Related Party Transactions
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Business Combination (Tables)
Summary of Significant Accounting Policies (Tables)
Equity Commitment and Share Purchase Option (Tables)
Fair Value Measurements (Tables)
Financial Statement Components (Tables)
Leases (Tables)
Equity-Based Compensation (Tables)
Net Loss Per Share (Tables)
Income Taxes (Tables)
Notes Details
Nature of Operations, Business Combination Transaction - (Details)
Risks and Liquidity - Additional Information (Details)
Business Combination - Additional Information (Details)
Business Combination - Schedule of Elements of Net Proceeds From Business Combination Transaction (Details)
Business Combination - Schedule of Number of Shares of Common Stock Outstanding Immediately Following Consummation of Business Combination Transaction (Details)
Summary of Significant Accounting Policies - A Reconciliation of the Cash, Cash Equivalents and Restricted Cash (Details)
Summary of Significant Accounting Policies - Summary of Depreciation and Amortization Expense Recognized Using Straight-Line Method (Details)
Summary of Significant Accounting Policies - Additional Information (Details)
Pfizer License Agreement - Additional Information (Details)
Equity Commitment and Share Purchase Option (Details)
Equity Commitment and Share Purchase Option - Summary of Key Inputs Used in Fair Value Calculation For Financial Instruments (Details)
Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)
Fair Value Measurements - Additional Information (Details)
Fair Value Measurements - Summary of Analysis of the Changes in the Equity Commitment (Details))
Fair Value Measurements - Summary of Analysis of the Changes in the Share Purchase Option (Details)
Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)
Financial Statement Components - Summary of Property and Equipment Net (Details)
Financial Statement Components - Additional Information (Details)
Financial Statement Components - Summary of Other Long-Term Assets (Details)
Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)
Financial Statement Components - Summary of Other Long-Term Liabilities (Details)
Financial Statement Components - Summary of Other Income (Expense), Net (Details)
Leases - Additional Information (Details)
Leases - Summary of Lease Cost Recognized (Details)
Leases - Summary of Lease Cost Recognized (Parenthetical) (Details)
Leases - Summary of Future Minimum Commitments Under Operating Leases (Details)
Leases - Summary of Operating Leases in Consolidated Balance Sheets (Details)
Stockholders' Equity, Preferred Stock and Common Stock (Details)
Stockholders' Equity, Warrants (Details)
Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)
Equity-Based Compensation - Additional Information (Details)
Equity-Based Compensation - Summary of Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)
Equity-Based Compensation - Summary of Stock Options Activity (Details)
Equity-Based Compensation - Summary of Restricted Stock Activity (Details)
Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)
Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)
Income Taxes - Schedule of Reconciliation of Provision for Income Tax Expenses Computed at Statutory Federal Income Tax Rate to Income Taxes (Details)
Income Taxes - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)
Income Taxes - Additional Information (Details)
Income Taxes - Schedule of Income Tax (Benefit) Provision (Details)
Commitments and Contingencies - Additional Information (Details)
Employee Benefit Plans - Additional Information (Details)
Related Party Transactions (Details)
Related Party Transactions, Management Agreement (Details)
All Reports